| Date Filed | Type | Description |
| 04/05/2023 |
4
| Olafsson Sigurdur O (President and CEO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 672,948 restricted stock units
@ $0 |
|
| 03/15/2023 |
4
| Olafsson Sigurdur O (President and CEO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Bought 3,000 shares
@ $8.3738, valued at
$25.1k
|
|
| 06/30/2022 |
3
| Olafsson Sigurdur O (President and CEO) has filed a Form 3 on Mallinckrodt plc |
| 05/10/2019 |
4
| Olafsson Sigurdur O (Director) has filed a Form 4 on Pfenex Inc.|
Txns:
| Granted 18,000 options to buy
@ $5.78, valued at
$104k
|
|
| 05/10/2018 |
4
| Olafsson Sigurdur O (Director) has filed a Form 4 on Pfenex Inc.|
Txns:
| Granted 18,000 options to buy
@ $6.33, valued at
$113.9k
|
|
| 05/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2013 |
4
| Olafsson Sigurdur O (PRES.-ACTAVIS PHARMA) has filed a Form 4 on Actavis plc|
Txns:
| Granted 96,947 shares
@ $0 |
|
| 10/03/2013 |
3
| Olafsson Sigurdur O (PRES.-ACTAVIS PHARMA) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2013 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 08/06/2013 |
4
| Olafsson Sigurdur O (Pres-Global Generics) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 4,500 shares
@ $135.4661, valued at
$609.6k
|
|
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/05/2013 |
4
| Olafsson Sigurdur O (Pres-Global Generics) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 3,702 shares
@ $85.54, valued at
$316.7k
|
|
| 09/05/2012 |
4
| Olafsson Sigurdur O (Pres-Global Generics) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 811 shares
@ $81.35, valued at
$66k
|
|
| 03/12/2012 |
4
| Olafsson Sigurdur O (EXEC VP, GLOBAL GENERICS) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 10,027 shares
@ $0
Granted 8,553 shares
@ $0 |
|
| 09/02/2010 |
4
| Olafsson Sigurdur O (EXEC VP, GLOBAL GENERICS) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 5,000 shares
@ $0
Granted 20,000 shares
@ $0 |
|
| 09/02/2010 |
3
| Olafsson Sigurdur O (EXEC VP, GLOBAL GENERICS) has filed a Form 3 on WATSON PHARMACEUTICALS INC |